KB 141

Known as: KB-141, KB141 cpd 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Phenyl EthersPhenylacetates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Analysis of the roles of mutations in thyroid hormone receptor-β by a bacterial biosensor system.
Mutations in thyroid hormone receptors (TRs) often lead to metabolic and developmental disorders, but patients with these… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2012
2012
Bacterial biosensors for screening isoform-selective ligands for human thyroid receptors α-1 and β-1
Subtype-selective thyromimetics have potential as new pharmaceuticals for the prevention or treatment of heart disease, high LDL… (More)
  • figure 1
  • table 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
2008
2008
Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor β subtype selective agonist KB-141
Selective thyroid hormone receptor subtype-beta (TRbeta) agonists have received attention as potential treatments for… (More)
Is this relevant?
Review
2008
Review
2008
Metabolic effects of thyroid hormone derivatives.
The processes and pathways mediating the intermediary metabolism of carbohydrates, lipids, and proteins are all affected by… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
Despite efforts spanning four decades, the therapeutic potential of thyroid hormone receptor (TR) agonists as lipid-lowering and… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
2007
2007
Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141.
Based on the scaffold of the pharmacologically selective thyromimetic 2b, structurally a close analog to KB-141 (2a), a number of… (More)
Is this relevant?
Review
2007
Review
2007
Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes.
Obesity and metabolic syndrome are increasing dramatically worldwide, contributing to cardiovascular morbidity and mortality… (More)
Is this relevant?
2006
2006
Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta.
Based on the examination of the X-ray crystallographic structures of the LBD of TRalpha and TRbeta in complex with KB-141 (2), a… (More)
Is this relevant?
Review
2005
Review
2005
Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects.
Few treatments for obesity exist and improvements for treatment of hyperlipidemia are still desirable. Thyroid hormone receptors… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability.
Few treatments for obesity exist and, whereas efficacious therapeutics for hyperlipidemia are available, further improvements are… (More)
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • table 1
Is this relevant?